Skip to content

Breathwork for Chronic Musculoskeletal Pain

Breathwork Intervention for Individuals With Chronic Musculoskeletal Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06455839
Enrollment
10
Registered
2024-06-12
Start date
2024-05-29
Completion date
2024-07-27
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Musculoskeletal Pain, Pain, Pain, Chronic

Brief summary

This project is a single-site, single-arm, clinical feasibility trial examining the impact of a single-session, 2-hour connected consciousness breathing with breath retention (CCBR) training for chronic musculoskeletal pain.

Detailed description

CCBR is a breathwork style that involves breathing with no pause between inhalation and exhalation (also known as circular breathing). This breathing pattern is maintained for a given period of time, ranging from 5 minutes to over 2 hours. In the proposed project, the CCBR training will begin with a 15-minute introduction to CCBR, followed by an hour and 15 minutes of therapist-guided CCBR practice. The final 30 minutes will be used to discuss participant experiences during the CCBR practice. CCBR training sessions will occur in-person and in a small group format (5 participants each).

Interventions

BEHAVIORALGuided Resipiration Mindfulness Therapy (GRMT)

GRMT provides training in respiratory regulation, mindfulness and relaxation. The GRMT training will begin with a 15-minute introduction to the treatment model, followed by an hour of therapist-guided respiration (i.e., continuous rhythmic expansion of the chest, and relaxed exhalation involving release of all respiratory and peripheral musculature). The final 45 minutes will be used to discuss participant experiences during the GRMT training. GRMT training sessions will occur in-person and in a small group format (\<5 participants each).

Sponsors

Florida State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* having received a professional diagnosis of clinical levels of chronic pain * being able to not commit to another (new) treatment during the course of the study * understanding English instructions fluently * Being 18 and above

Exclusion criteria

* having learned to practice breathwork any time in the past * being unable to perform most basic tasks due to pain or pain treatment.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Chronic Pain Recruited1 weekExamine recruitment rates during the 1 week of recruitment.
Intervention Adherence2 HoursExamine the percentage of participants completing their 2-hour intervention session.
Treatment AcceptabilityCompleted immediately after the 2-hour GRMT trainingTreatment acceptability will be assessed with a 12-item adaptation of the Treatment Framework of Acceptability questionnaire. Scores range from 5 to 45. Higher scores reflect greater acceptability.

Secondary

MeasureTime frameDescription
Global Impression of ChangeCompleted at 2- and 6-week follow-upsTreatment related improvement will be assessed with the Patient Global Impression of Change scale. Scores range from 0 to 7, with higher scores reflecting greater treatment related improvement.

Other

MeasureTime frameDescription
Chronic PainBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in chronic pain from baseline through 6-week follow-up will be assessed with the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 10, with higher scores reflecting greater chronic pain.
SleepBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in sleep from baseline through 6-week follow-up will be assessed with the PROMIS Sleep Disturbance Short Form. Scores range from 6 to 30, with higher scores reflecting worse sleep.
Pain CatastrophizingBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in pain catastrophizing from baseline through 6-week follow-up will be assessed with the Pain Catastrophizing Scale. Scores range from 0 to 52, with higher scores reflecting greater pain catastrophizing.
DepressionBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in depression from baseline through 6-week follow-up will be assessed with the Patient Health Questionnaire-2. Scores range from 0 to 6, with higher scores reflecting greater depression.
Acute Pain UnpleasantnessWill be completed immediately before and after the 2-hour intervention sessionChange in acute pain unpleasantness will be measured with an individual item (How unpleasant is your pain, right now?) rated on a numeric rating scale. Scores range from 0 to 10, with higher scores reflecting greater acute pain unpleasantness.
Prescription Pain Medication UseBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in prescription pain medication misuse from baseline through 6-week follow-up will be assessed with the PROMIS Prescription Pain Medication Misuse Short Form. Scores range from 7 to 35, with higher scores reflecting greater medication misuse.
Mindful Pain ManagementBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in the use of mindfulness for pain management from baseline through 6-week follow-up will be assessed with the Mindful Reappraisal of Pain Scale. Scores range from 0 to 54, with higher scores reflecting greater mindful pain management.
Self-Transcendent ExperiencesBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in the the frequency of self-transcendent experiences from baseline through 6-week follow-up will be assessed with the Nondual Awareness Dimensional Assessment. Scores range from 0 to 5, with higher scores reflecting more frequent self-transcendent experiences.
AnxietyBaseline, 2 weeks post-treatment, 6 week post-treatmentChange in anxiety from baseline through 6-week follow-up will be assessed with the Generalized Anxiety Disorder 2-item. Scores range from 0 to 6, with higher scores reflecting greater anxiety.
Acute Pain IntensityWill be completed immediately before and after the 2-hour intervention sessionChange in acute pain intensity will be measured with an individual item (How much pain do you have, right now?) rated on a numeric rating scale. Scores range from 0 to 10, with higher scores reflecting greater acute pain intensity.
Daily Pain IntensityDaily for 6 weeksChange in daily pain intensity from from the first post-intervention day through the 6-week follow-up will be assessed with the pain intensity item from the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 10, with higher scores reflecting greater pain intensity.
Daily Pain InterferenceDaily for 6 weeksChange in daily pain interference from from the first post-intervention day through the 6-week follow-up will be assessed with the two pain interference items from the Pain, Enjoyment, and General Activity scale. Scores range from 0 to 10, with higher scores reflecting greater pain interference.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026